AI identifies TNIK protein and creates a drug that rewinds lung damage in pulmonary fibrosis, a breakthrough never seen before

AI DISCOVERS REVOLUTIONARY NEW WAY TO REVERSE LUNG DAMAGE

An AI system didn’t just design a new drug for pulmonary fibrosis; it first figured out which protein was causing the damage (TNIK), then designed a molecule to shut it down.

In a 12-week trial, patients on the highest dose gained almost 100 ml of lung capacity, something that’s never been achieved before with any other drug.

For a disease that usually only gets worse, that’s like hitting rewind on the damage.

Source: Nature Medicine